The aptitude of Ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic conditions. Ropinirole, widely used in treatment of motor fluctuations of Parkinson’s Disease, passes the buccal mucosa. Flux and permeability coefficient values suggested that the membrane does not appear a limiting step to the drug absorption. Nevertheless, an initial lag time is observed but the input rate can be modulated by permeation enhancement using Limonene or by application of electric fields. Absorption improvement was accompanied by the important reduction of the lag time; at once the time required to reach the steady state plasma concentration was drastically decreased. On the basis of these results we could assume that clinical application of Ropinirole by buccal delivery is feasible

De Caro, V., Giandalia, G., Siragusa, M.G., Sutera, F.M., & Giannola, L.I. (2012). New prospective in treatment of Parkinson’s disease: Studies on permeation of ropinirole through buccal mucosa. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 429(1-2), 78-83 [10.1016/j.ijpharm.2012.03.022].

New prospective in treatment of Parkinson’s disease: Studies on permeation of ropinirole through buccal mucosa

DE CARO, Viviana;GIANDALIA, Giulia;SIRAGUSA, Maria Gabriella;SUTERA, Flavia Maria;GIANNOLA, Libero Italo
2012

Abstract

The aptitude of Ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic conditions. Ropinirole, widely used in treatment of motor fluctuations of Parkinson’s Disease, passes the buccal mucosa. Flux and permeability coefficient values suggested that the membrane does not appear a limiting step to the drug absorption. Nevertheless, an initial lag time is observed but the input rate can be modulated by permeation enhancement using Limonene or by application of electric fields. Absorption improvement was accompanied by the important reduction of the lag time; at once the time required to reach the steady state plasma concentration was drastically decreased. On the basis of these results we could assume that clinical application of Ropinirole by buccal delivery is feasible
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
De Caro, V., Giandalia, G., Siragusa, M.G., Sutera, F.M., & Giannola, L.I. (2012). New prospective in treatment of Parkinson’s disease: Studies on permeation of ropinirole through buccal mucosa. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 429(1-2), 78-83 [10.1016/j.ijpharm.2012.03.022].
File in questo prodotto:
File Dimensione Formato  
Int J Pharm 429 (2012) 78-83.pdf

Solo gestori archvio

Descrizione: Articolo principale
Dimensione 277.47 kB
Formato Adobe PDF
277.47 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/62802
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 34
social impact